CASI Pharmaceuticals Inc. (NASDAQ: CASI)
$2.7500
+0.1000 ( -3.07% ) 13.0K
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
Market Data
Open
$2.7500
Previous close
$2.6500
Volume
13.0K
Market cap
$39.58M
Day range
$2.5500 - $2.8370
52 week range
$2.0500 - $8.1900
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Form 6-K | 1 | Dec 16, 2024 |
| 6-k | Form 6-K | 3 | Nov 15, 2024 |
| 6-k | Form 6-K | 1 | Sep 12, 2024 |
| 6-k | Form 6-K | 3 | Aug 16, 2024 |
| 6-k | Form 6-K | 1 | Jul 19, 2024 |
| 6-k | Form 6-K | 3 | Jul 08, 2024 |
| 6-k | Form 6-K | 3 | Jun 27, 2024 |
| 6-k | Form 6-K | 3 | Jun 27, 2024 |
| 6-k | Form 6-K | 3 | May 15, 2024 |
| 6-k | Form 6-K | 1 | Apr 08, 2024 |